Pulmonary rehabilitation (PR) is useful in survivors of COVID-19-associated acute respiratory failure (ARF). The aim of this retrospective study on in-patient PR was to report rehabilitative trajectories and effects of cycle training.
METHODS:
According to the Short Physical Performance Battery (SPPB) score at admission (T0), participants were allocated to stage 1 (SPPB < 6), stage 2 (SPPB ≥ 6 and < 10), or stage 3 (SPPB ≥ 10) and performed increasing level of activities from passive exercises to free walking, balance exercises, strength exercises, and tailored cycle-ergometer endurance training. The primary outcome was SPPB. 6-min walk distance (6MWD), Medical Research Council score, Barthel dyspnea index, and rate of subjects able to cycling were also assessed.
RESULTS:
Data of 123 participants were analyzed. At T0, 44 (35.8%), 50 (40.6%), and 29 (23.6%) participants were allocated to stages 1–3, respectively. At discharge, participants showed significant improvements in SPPB, independent of the initial stage, 81 (65.8%) improving more than its minimal clinically important difference. At T1, the proportion of participants in stages 1 and 2 decreased, whereas significantly increased in stage 3 (P = .003), (being 9.8%, 33.3%, and 56.9% for stages 1–3, respectively; P <.001). Sixty-nine of 123 participants (56.1%) underwent cycle exercise training. In participants able to perform it, 6MWD improved by 115 (65–240) m and 60 (40–118) m in participants with and without exercise-induced desaturation, respectively, with significant difference between groups (P = .044).
CONCLUSIONS:
In-patient PR could be tailored and progressively increased to survivors of COVID-19-associated ARF; cycle training was feasible in half of the participants. Benefits were independent of initial stage of physical performance and allowed participants to move from lower to higher levels of activities.
WinckJC, AmbrosinoN. COVID-19 pandemic and noninvasive respiratory management: every Goliath needs a David. An evidence-based evaluation of problems. Pulmonology, 2020; 26(4):213-220.
2.
WanS, LiM, YeZ, YangC, CaiQ, DuanS, SongB. CT manifestations and clinical characteristics of 1,115 subjects with coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis. Acad Radiol, 2020; 27(7):910-921.
3.
Torres-CastroR, Vasconcello-CastilloL, Alsina-RestoyX, Solis-NavarroL, BurgosF, PuppoH, et al. Respiratory function in patients with post infection by COVID-19: a systematic review and meta-analysis. Pulmonology, 2021; 27(4):328-337.
4.
PaneroniM, SimonelliC, SaleriM, BertacchiniL, VenturelliM, TroostersT, et al. Muscle strength and physical performance in patients without previous disabilities recovering from COVID-19 pneumonia. Am J Phys Med Rehabil, 2021; 100(2):105-109.
5.
SimonelliC, PaneroniM, VitaccaM, AmbrosinoN. Measures of physical performance in COVID-19 patients: a mapping review. Pulmonology, 2021; 27(6):518-528.
6.
HuangC, HuangL, WangY, LiX, RenL, GuX, et al. Six-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet, 2021; 397(10270):220-232.
7.
WuX, LiuX, ZhouY, YuH, LiR, ZhanQ, et al. Three-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19–related hospitalization: a prospective study. Lancet Respir Med, 2021; 9(7):747-754.
8.
SpruitMA, SinghSJ, GarveyC, ZuWallackR, NiciL, RochesterC, et al. ATS/ERS Task Force on Pulmonary Rehabilitation. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med, 2013; 188(8):e13-64.
9.
PaneroniM, VitaccaM, VenturelliM, SimonelliC, BertacchiniL, ScalviniS, et al. The impact of exercise training on fatigue in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. Pulmonology, 2020; 26(5):304-313.
VitaccaM, CaroneM, CliniEM, PaneroniM, LazzeriM, LanzaA, et al. ITS-AIPO, the ARIR and the SIP/IRS. Joint statement on the role of respiratory rehabilitation in the COVID-19 crisis: The Italian position paper. Respiration, 2020; 99(6):493-499.
12.
ZampognaE, PaneroniM, BelliS, AlianiM, GandolfoA, ViscaD, et al. Pulmonary rehabilitation in patients recovering from COVID-19. Respiration, 2021; 100(5):416-422.
13.
GloecklR, LeitlD, JaroschI, SchneebergerT, NellC, StenzelN, et al. Benefits of pulmonary rehabilitation in COVID-19: a prospective observational cohort study. ERJ Open Res, 2021; 7(2):00108-2021.
14.
CerianaP, NavaS, VitaccaM, CarlucciA, PaneroniM, SchreiberA, et al. Noninvasive ventilation during weaning from prolonged mechanical ventilation. Pulmonology, 2019; 25(6):328-333.
15.
MaestriR, BruschiC, FracchiaC, PinnaGD, FanfullaF, AmbrosinoN. Physiological and clinical characteristics of patients with COPD admitted to an in-patient pulmonary rehabilitation program: A real-life study. Pulmonology, 2019; 25(2):71-78.
16.
VitaccaM, MiglioriGB, SpanevelloA, MelazziniMG, AmbrosinoN, CerianaP, et al. COVID-19 ICS Maugeri IRCCS network. Management and outcomes of post-acute COVID-19 patients in Northern Italy. Eur J Intern Med, 2020; 78:159-160.
17.
IppolitoM, VitaleF, AccursoG, IozzoP, GregorettiC, GiarratanoA, et al. Medical masks and respirators for the protection of health care workers from SARS-CoV-2 and other viruses. Pulmonology, 2020; 26(4):204-212.
18.
Bernabeu-MoraR, Medina-MirapeixF, Llamazares-HerránE, García-GuillamónG, Giménez-GiménezLM, Sánchez-NietoJM. The Short Physical Performance Battery is a discriminative tool for identifying patients with COPD at risk of disability. COPD, 2015; 10:2619-2626.
19.
GuralnikJM, SimonsickEM, FerrucciL, GlynnRJ, BerkmanLF, BlazerDG, et al. A Short Physical Performance Battery assessing lower-extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol, 1994; 49(2):M85-94.
MillerMR, HankinsonJ, BrusascoV, BurgosF, CasaburiR, CoatesA, et al. ATS/ERS Task Force. Standardization of spirometry. Eur Respir J, 2005; 26(2):319-338.
25.
QuanjerPH, StanojevicS, ColeTJ, BaurX, HallGL, CulverBH, et al. ERS Global Lung Function Initiative. Multi-ethnic reference values for spirometry for the 3–95-y age range: the global lung function 2012 equations. Eur Respir J, 2012; 40(6):1324-1343.
26.
PereraS, ModySH, WoodmanRC, StudenskiSA. Meaningful change and responsiveness in common physical performance measures in older adults. J Am Geriatr Soc, 2006; 54(5):743-749.
27.
HollandAE, SpruitMA, TroostersT, PuhanMA, PepinV, SaeyD, et al. An official European Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease. Eur Respir J, 2014; 44(6):1428-1446.
28.
EnrightPL, SherrillDL. Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med, 1998; 158(5 Pt 1):1384-1387.
29.
BestallJC, PaulEA, GarrodR, GarnhamR, JonesPW, WedzichaJA. Usefulness of the Medical Research Council (MRC) dyspnea scale as a measure of disability in patients with chronic obstructive pulmonary disease.Thorax, 1999; 54(7):581-586.
30.
VitaccaM, PaneroniM, BaiardiP, De CarolisV, ZampognaE, BelliS, et al. Development of a Barthel index based on dyspnea for patients with respiratory diseases. COPD, 2016; 11:1199-1206.
31.
VitaccaM, MaloviniA, BalbiB, AlianiM, CirioS, SpanevelloA, et al. Minimal clinically important difference in Barthel index dyspnea in patients with COPD. COPD, 2020; Volume 15:2591-2599.
32.
ThomasP, BaldwinC, BissettB, BodenI, GosselinkR, GrangerCL, et al. Physiotherapy management for COVID-19 in the acute hospital setting: clinical practice recommendations. J Physiother, 2020; 66(2):73-82.
33.
GeorgePM, BarrattSL, CondliffeR, DesaiSR, DevarajA, ForrestI, et al. Respiratory follow-up of patients with COVID-19 pneumonia. Thorax, 2020; 75(11):1009-1016.
34.
SpruitMA, HollandAE, SinghSJ, ToniaT, WilsonKC, TroostersT. COVID-19: interim guidance on rehabilitation in the hospital and post-hospital phase from a European Respiratory Society and American Thoracic Society–coordinated international task force. Eur Respir J, 2020; 56(6):2002197.
35.
ZampognaE, AmbrosinoN, SaderiL, SotgiuG, BottiniP, PignattiP, et al. Time course of exercise capacity in patients recovering from COVID-19-associated pneumonia. J Bras Pneumol, 2021; 47(4). e20210076.
36.
CarlucciA, PaneroniM, CarotenutoM, BertellaE, CirioS, GandolfoA, et al. Prevalence of exercise-induced oxygen desaturation after recovery from SARS-CoV-2 pneumonia and use of lung ultrasound to predict need for pulmonary rehabilitation. Pulmonology, 2021; S2531-0437(21)00117-3.
37.
VitaccaM, PaneroniM, BrunettiG, CarlucciA, BalbiB, SpanevelloA, AmbrosinoN. Physiological and symptom characteristics of survivors of COVID-19-associated pneumonia, with resting normoxemia and exercise-induced desaturation. Respir Care, 2021; 66(11):1657-1664.
38.
BianchiL, FoglioK, PortaR, BaiardiP, VitaccaM, AmbrosinoN. Lack of additional effect of adjunct of assisted ventilation to pulmonary rehabilitation in mild COPD patients. Respir Med, 2002; 96(5):359-367.
39.
OliveiraA, MachadoA, MarquesA. Minimal important and detectable differences of respiratory measures in outpatients with AECOPD. COPD, 2018; 15(5):479-488.
40.
SimonnetA, ChetbounM, PoissyJ, RaverdyV, NouletteJ, DuhamelA, et al. LICORN and the Lille COVID-19 and Obesity Study Group. High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation. Obesity (Silver Spring), 2020; 28(7):1195-1199.
41.
PaneroniM, VitaccaM, BernocchiP, BertacchiniL, ScalviniS. Feasibility of tele-rehabilitation in survivors of COVID-19 pneumonia. Pulmonology, 2022; 28(2):152-154.
